ASSESSMENT OF CANCER-RELATED FATIGUE ON THE LIVES OF THE PATIENTS
Session type: Proffered paper sessions
Cancer- Related Fatigue (CRF) is a debilitating, multifaceted biopsychosocial symptom experienced by cancer survivors, begins after diagnosis, persists long after treatments end, even when cancer is in remission.
The study conducted at National Institute of Cancer Research & Hospital, Ahsania Mission Cancer & General Hospital, Dhaka; from January - December 2016, assessed the level of fatigue, using FACT-F scale,version 4.
Among 267 patients, 55.8% were male. The majority (40.1%) were in 36-55 age group. The mean age was 46.11 (SD ± 16.548) years, with minimum 16 & maximum 83 years. Larger part (15.7%) were affected by GIT cancer, 15% Breast cancer, 14.2% Lung cancer, 12.4% Ca Head-Neck, 10.5% Soft tissue Sarcoma, 10.1% Gynaecological cancer, 7.9% Genitourinary cancer, 7.9% Haematological cancer, & rest Ca Brain-PNS-Spinal cord, Melanoma, Skin, CUP. Majority (87.3%) were suffering for 1-12 months. Greater part (47.6%) belonged to the stage II. Majority (49.4%) were moderately anemic. Majority (37.1%) were receiving Chemotherapy, 21.3% Surgery & Chemotherapy, 15.4% Concurrent Chemo-Radiation therapy, 9.0% Radiotherapy, 7.1% Surgical treatment. Better part (76.4%) were receiving treatment regularly. Fatigue was present in 79.4% patients, where 4.5% severely fatigued, 28.5% moderately fatigued, 46.4% mildly fatigued. The Greater part (53.2%) patients' family- social life, financial condition was seriously hampered. The majority (65.2%) were facing extreme financial difficulties due to physical condition & medical treatment. Mental condition was vulnerable in 43.8%. Functional well being was bad in 15.7% patients, 34.8% were completely unable to work outside & perform strenuous activities. Fatigue level was associated with Sex (P = 0.000 ), Income (P = 0.014), and Cancer stage of the respondents (P = 0.002 ).
This research evaluates socio-economic aspects of fatigue in cancer patients, will yield positive outcomes in them with different diagnosis undergoing different modalities of anti-neoplastic treatments & strategies to facilitate reliable assessment of symptoms of CRF.